Clene to Present at H.C. Wainwright 26th Annual Global Investment Conference
Clene (CLNN) to present at H.C. Wainwright 26th Annual Global Investment Conference, highlighting latest achievements and updates, including promising results for neurological function restoration.
This news showcases Clene's latest achievements and updates, providing hope for patients with neurodegenerative conditions. The company's research and drug development efforts could potentially lead to new treatment options for conditions like ALS and MS, impacting the lives of many individuals.
